SCHEMBL30693702

SCHEMBL30693702

CC1(C)OB(c2ccc(CNC(=O)c3ccccc3)cc2)OC1(C)C

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.70
CA2 P00918 2/20 0.70
CA9 Q16790 2/20 0.70
KEAP1 Q14145 1/20 0.56
NFE2L2 Q16236 1/20 0.56
HDAC1 Q13547 6/20 0.56
HDAC6 Q9UBN7 5/20 0.56
HDAC3 O15379 4/20 0.52
P4HB P07237 1/20 0.52
HDAC2 Q92769 4/20 0.50
KDM4E B2RXH2 1/20 0.49
POLB P06746 1/20 0.49
TSHR P16473 1/20 0.49
RECQL P46063 1/20 0.49
LMNA P02545 1/20 0.49
RAB9A P51151 1/20 0.49
ERCC1 P07992 1/20 0.49
ERCC4 Q92889 1/20 0.49
EPHX2 P34913 1/20 0.49
NR1H4 Q96RI1 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2355046 0.95 CA2 (0.70) CA1CA2CA9KEAP1NFE2L2
SCHEMBL17645779 0.86 CA1 (0.69) CA1CA2CA9HDAC6HDAC3
SCHEMBL31259610 0.86 HDAC2 (0.56) CA1CA2CA9KEAP1NFE2L2
SCHEMBL2572162 0.84 CA1 (0.60) CA1CA2CA9KEAP1NFE2L2
SCHEMBL22498702 0.83 CA1 (0.63) CA1CA2CA9KEAP1NFE2L2
SCHEMBL5675802 0.83 NPC1 (0.62) CA1CA2CA9KEAP1NFE2L2
SCHEMBL17339660 0.82 CA1 (0.59) CA1CA2CA9POLBLMNA
SCHEMBL26922431 0.82 CA1 (0.56) CA1CA2CA9KEAP1NFE2L2
SCHEMBL17339278 0.82 CA1 (0.56) CA1CA2CA9KEAP1NFE2L2
SCHEMBL16899331 0.82 CA1 (0.71) CA1CA2CA9HDAC6HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4540228-A1 ALDH-2 INHIBITOR COMPOUNDS AND METHODS OF USE Amygdala Neurosciences, Inc. (US) 2025-04-23 EP disclosed
WO-2023244563-A1 ALDH-2 INHIBITOR COMPOUNDS AND METHODS OF USE AMYGDALA NEUROSCIENCES, INC. (US) 2023-12-21 WO disclosed